Skip to content

PODD 2022 – How drug delivery is enabling a clinical trial for Glioblastoma

TargTex CEO Dr João Seixas and Nanoform CCO Christian Jones presented highly promising in-vivo data, enabled by a nanoformed drug product for the treatment of glioblastoma multiforme (GBM), at the PODD Conference (Partnerships and Opportunities in Drug Delivery), in Boston USA.